We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
-12.83%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$30M
AUM Growth
-$32.6M
Cap. Flow
-$26.3M
Cap. Flow %
-87.72%
Top 10 Hldgs %
87.22%
Holding
32
New
1
Increased
4
Reduced
17
Closed
9

Top Buys

1
AMZN icon
Amazon
AMZN
+$201K
2
EHTH icon
eHealth
EHTH
+$75.5K
3
KRNT icon
Kornit Digital
KRNT
+$68.5K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$32.3K
5
CRM icon
Salesforce
CRM
+$10.4K

Top Sells

1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$8.65M
2
RCM
R1 RCM Inc. Common Stock
RCM
+$5.97M
3
ABT icon
Abbott
ABT
+$5.75M
4
CVS icon
CVS Health
CVS
+$3.29M
5
ADT icon
ADT
ADT
+$773K

Sector Composition

1 Healthcare 45.23%
2 Industrials 26.49%
3 Financials 12.72%
4 Technology 10.16%
5 Communication Services 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCM
1
DELISTED
R1 RCM Inc. Common Stock
RCM
$7.07M 23.58%
562,687
-480,313
-46% -$5.97M
ZBH icon
2
Zimmer Biomet
ZBH
$17.6B
$6.26M 20.9%
57,700
-38
-0.1% -$4.48K
CVS icon
3
CVS Health
CVS
$137B
$5.92M 19.75%
100,229
-52,517
-34% -$3.29M
EHTH icon
4
eHealth
EHTH
$47.3M
$2.72M 9.07%
600,000
+15,000
+3% +$75.5K
VYNE icon
5
VYNE Therapeutics
VYNE
$25.4M
$1.37M 4.58%
696,465
– –
KRNT icon
6
Kornit Digital
KRNT
$696M
$870K 2.9%
59,439
+4,439
+8% +$68.5K
META icon
7
Meta Platforms (Facebook)
META
$1.64T
$523K 1.75%
1,038
-21
-2% -$10.2K
MSFT icon
8
Microsoft
MSFT
$2.93T
$521K 1.74%
1,166
-89
-7% -$37.6K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.23T
$511K 1.71%
2,806
-942
-25% -$159K
NFLX icon
10
Netflix
NFLX
$290B
$374K 1.25%
5,540
-610
-10% -$38.1K
V icon
11
Visa
V
$682B
$373K 1.25%
1,422
-69
-5% -$18.9K
MA icon
12
Mastercard
MA
$480B
$372K 1.24%
843
-19
-2% -$8.65K
BRK.B icon
13
Berkshire Hathaway Class B
BRK.B
$1.06T
$350K 1.17%
861
+79
+10% +$32.3K
CRM icon
14
Salesforce
CRM
$140B
$335K 1.12%
1,302
+39
+3% +$10.4K
NVDA icon
15
NVIDIA
NVDA
$4.91T
$319K 1.06%
2,580
-640
-20% -$64.7K
ADBE icon
16
Adobe
ADBE
$94.3B
$318K 1.06%
572
-60
-9% -$29.1K
AAPL icon
17
Apple
AAPL
$4.9T
$311K 1.04%
1,477
-88
-6% -$16.4K
ORCL icon
18
Oracle
ORCL
$364B
$303K 1.01%
2,145
-176
-8% -$21.9K
ACN icon
19
Accenture
ACN
$87.9B
$274K 0.91%
903
-66
-7% -$20.2K
INTU icon
20
Intuit
INTU
$79.6B
$247K 0.82%
376
-33
-8% -$20.5K
NOW icon
21
ServiceNow
NOW
$106B
$217K 0.72%
1,380
-110
-7% -$16.1K
AMZN icon
22
Amazon
AMZN
$2.66T
$211K 0.7%
+1,092
New +$201K
IBM icon
23
IBM
IBM
$200B
$200K 0.67%
1,159
-92
-7% -$16K
ABT icon
24
Abbott
ABT
$175B
– –
-50,550
Closed -$5.75M
ADT icon
25
ADT
ADT
$5.13B
– –
-115,000
Closed -$773K
1
2

Similar funds

RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

DSC Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, DSC Advisors held 32 positions worth $30M, down 52% from $62.6M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

DSC Advisors withdrew a net $26.3M in Q2 2024, closing 9 positions and reducing 17 holdings. Its most notable exit was BioMarin Pharmaceuticals, an estimated $8.65M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 58% a quarter earlier, followed by Industrials and Financials.

Against the trend, DSC Advisors opened a new position in Amazon worth $211K.

  • DSC Advisors's largest Q2 2024 buy was Amazon: 1,092 shares worth $211K.
  • DSC Advisors added most to eHealth in Q2 2024, an estimated $75.5K increase.
  • DSC Advisors's biggest Q2 2024 reduction was R1 RCM Inc. Common Stock, cutting an estimated $5.97M.
  • DSC Advisors fully exited BioMarin Pharmaceuticals in Q2 2024, selling an estimated $8.65M.
  • DSC Advisors's ten largest holdings make up 87% of its $30M portfolio in Q2 2024.
  • DSC Advisors opened 1 new position and closed 9 in Q2 2024.
  • DSC Advisors's portfolio value fell 52% quarter-over-quarter to $30M.

Based on DSC Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.